Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer

NCT06357598 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-small-cell Lung Cancer (NSCLC)

Interventions

DRUG: Tislelizumab
DRUG: Pemetrexed (Non-squamous NSCLC) or Nab-paclitaxel(Squamous NSCLC)
DRUG: Carboplatin or Cisplatin
PROCEDURE: Surgery

Sponsor

The Affiliated Hospital of Qingdao University